{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T15:13:23Z","timestamp":1766157203223,"version":"3.48.0"},"reference-count":24,"publisher":"FapUNIFESP (SciELO)","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"am","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["ABCD, arq. bras. cir. dig."],"abstract":"<jats:p>ABSTRACT  Background:  Perioperative chemotherapy is the standard curative treatment for resectable gastric adenocarcinoma, significantly improving both overall and recurrence-free survival. The histological response to neoadjuvant therapy is a critical prognostic factor, commonly assessed through grading systems such as Mandard\u2019s tumor regression grade (TRG).  Aims:  The aim of the study was to identify predictive factors for histological response to neoadjuvant therapy in gastric adenocarcinoma.  Methods:  A retrospective study was performed on patients with gastric adenocarcinoma who underwent surgery following neoadjuvant chemotherapy, from 2015 to 2020. The histological response was evaluated using Mandard TRG, which includes five grades (1\u20135), based on the proportion of residual viable tumor cells and fibrosis. Grades 1\u20133 were considered a response, and Grades 4 and 5 were considered no response. Students\u2019 t-test, chi-squared test, and multivariate logistic regression were used, with significance set at p&lt;0.05.  Results:  Forty patients were included (male-to-female ratio 2.64, mean age 63 years). Histological response (TRG 1\u20133) was observed in 48%, while 52% showed no response (TRG 4\u20135). Univariate analysis showed significant correlations between histological response and tumor size &gt;38 mm (p=0.03), differentiation (p=0.02), parietal wall invasion, absence of nodal involvement (both p&lt;0.001), pathological tumor, node, and metastasis stage (p&lt;0.001), and absence of vascular and perineural invasion (both p=0.001). Multivariate analysis identified parietal wall invasion (odds ratio=2.351, p=0.022) and absence of lymph node metastases (odds ratio=1.491, p=0.01) as independent predictive factors.  Conclusions:  Parietal wall invasion and absence of nodal metastases are predictive of histological response to neoadjuvant therapy in gastric adenocarcinoma.<\/jats:p>","DOI":"10.1590\/0102-67202025000043e1912","type":"journal-article","created":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T15:05:15Z","timestamp":1766156715000},"source":"Crossref","is-referenced-by-count":0,"title":["Predictive factors for histological response to neoadjuvant therapy in gastric adenocarcinomas"],"prefix":"10.1590","volume":"38","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8430-0072","authenticated-orcid":false,"given":"Dhouha","family":"BACHA","sequence":"first","affiliation":[{"name":"Mongi Slim University Hospital,  Tunisia; University Tunis El Manar,  Tunisia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-9042-280X","authenticated-orcid":false,"given":"Nour","family":"BOUDRIGUA","sequence":"additional","affiliation":[{"name":"Mongi Slim University Hospital,  Tunisia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-9269-8365","authenticated-orcid":false,"given":"Ines","family":"MALLEK","sequence":"additional","affiliation":[{"name":"Mongi Slim University Hospital,  Tunisia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-7741-2546","authenticated-orcid":false,"given":"Saf\u00e9","family":"CHAMMEM","sequence":"additional","affiliation":[{"name":"Mongi Slim University Hospital,  Tunisia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9023-7869","authenticated-orcid":false,"given":"Monia","family":"ATTIA","sequence":"additional","affiliation":[{"name":"Mongi Slim University Hospital,  Tunisia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-3969-9751","authenticated-orcid":false,"given":"Lassaad","family":"GHARBI","sequence":"additional","affiliation":[{"name":"University Tunis El Manar,  Tunisia; Mongi Slim University Hospital,  Tunisia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7071-4592","authenticated-orcid":false,"given":"Ahlem","family":"LAHMAR","sequence":"additional","affiliation":[{"name":"Mongi Slim University Hospital,  Tunisia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8897-398X","authenticated-orcid":false,"given":"Sana","family":"BEN-SLAMA","sequence":"additional","affiliation":[{"name":"Mongi Slim University Hospital,  Tunisia"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"530","published-online":{"date-parts":[[2025]]},"reference":[{"issue":"6","key":"ref1","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1200\/JCO.2005.01.305","article-title":"Paclitaxel-based chemoradiotherapy in localized gastric carcinoma: degree of pathologic response and not clinical parameters dictated patient outcome","volume":"23","author":"Ajani JA","year":"2005","journal-title":"J Clin Oncol"},{"key":"ref2","article-title":"Histological response of gastric adenocarcinomas after chemotherapy in Tunisian population","volume":"38","author":"Bacha D","year":"2025","journal-title":"Arq Bras Cir Dig"},{"issue":"7","key":"ref3","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1002\/cncr.11660","article-title":"Histomorphology and grading of regression in gastric carcinoma treated with neoadjuvant chemotherapy","volume":"98","author":"Becker K","year":"2003","journal-title":"Cancer"},{"key":"ref4","series-title":"Handbuch spez pathol anat und histo","first-page":"864","author":"Borrmann R","year":"1926"},{"key":"ref5","series-title":"American Joint Committee on Cancer","author":"Byrd DR","year":"2017"},{"issue":"19","key":"ref6","doi-asserted-by":"crossref","first-page":"2427","DOI":"10.3748\/wjg.v26.i19.2427","article-title":"Nomogram for predicting pathological complete response to neoadjuvant chemotherapy in patients with advanced gastric cancer","volume":"26","author":"Chen YH","year":"2020","journal-title":"World J Gastroenterol"},{"issue":"2","key":"ref7","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/s10120-011-0041-5","article-title":"Japanese classification of gastric carcinoma: 3rd English edition","volume":"14","year":"2011","journal-title":"Gastric Cancer"},{"issue":"1","key":"ref8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10120-022-01331-8","article-title":"Japanese Gastric Cancer Treatment Guidelines 2021 (6th edition)","volume":"26","year":"2023","journal-title":"Gastric Cancer"},{"issue":"12","key":"ref9","doi-asserted-by":"crossref","first-page":"4359","DOI":"10.31557\/APJCP.2024.25.12.4359","article-title":"Estimated cancer incidence in Northern Tunisia in 2023: Northern Tunisia Cancer Registry","volume":"25","author":"Khiari H","year":"2024","journal-title":"Asian Pac J Cancer Prev"},{"issue":"8","key":"ref10","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1002\/jso.23009","article-title":"Neoadjuvant chemotherapy with FOLFOX: improved outcomes in Chinese patients with locally advanced gastric cancer","volume":"105","author":"Li ZY","year":"2012","journal-title":"J Surg Oncol"},{"issue":"1","key":"ref11","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/s12885-023-10513-1","article-title":"Risk model and factors for prediction of response to neoadjuvant chemotherapy in patients with advanced gastric cancer\u2014a two-center cohort study","volume":"23","author":"Liang XW","year":"2023","journal-title":"BMC Cancer"},{"key":"ref12","doi-asserted-by":"crossref","DOI":"10.1016\/j.critrevonc.2022.103841","article-title":"Characteristics of gastric cancer around the world","volume":"181","author":"L\u00f3pez MJ","year":"2023","journal-title":"Crit Rev Oncol Hematol"},{"issue":"10","key":"ref13","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1016\/j.annonc.2022.07.004","article-title":"Gastric cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up","volume":"33","author":"Lordick F","year":"2022","journal-title":"Ann Oncol"},{"issue":"7","key":"ref14","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.1245\/s10434-012-2254-1","article-title":"Prediction of response and prognosis by a score including only pretherapeutic parameters in 410 neoadjuvant treated gastric cancer patients","volume":"19","author":"Lorenzen S","year":"2012","journal-title":"Ann Surg Oncol"},{"issue":"11","key":"ref15","doi-asserted-by":"crossref","first-page":"2680","DOI":"10.1002\/1097-0142(19940601)73:11<2680::AID-CNCR2820731105>3.0.CO;2-C","article-title":"Pathologic assessment of tumor regression after preoperative chemoradiotherapy of esophageal carcinoma","volume":"73","author":"Mandard AM","year":"1994","journal-title":"Cancer"},{"issue":"2","key":"ref16","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1111\/his.13975","article-title":"The 2019 WHO classification of tumours of the digestive system","volume":"76","author":"Nagtegaal ID","year":"2020","journal-title":"Histopathology"},{"issue":"1","key":"ref17","doi-asserted-by":"crossref","first-page":"8","DOI":"10.21037\/cco-23-129","article-title":"Perioperative or neoadjuvant chemotherapy for locally advanced gastric or gastroesophageal junction cancer: from independent evidence in the West, the East, and Japan to global collaboration","volume":"13","author":"Nakayama I","year":"2024","journal-title":"Chin Clin Oncol"},{"key":"ref18","doi-asserted-by":"crossref","DOI":"10.1590\/0102-67202025000035e1904","article-title":"Surgical treatment of gastric adenocarcinoma: what factors influence the prognosis?","volume":"38","author":"Naufel Junior CR","year":"2025","journal-title":"Arq Bras Cir Dig"},{"key":"ref19","series-title":"Cancer Protocols","author":"Tang LH","year":"2014"},{"issue":"6","key":"ref20","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1002\/bjs.9484","article-title":"Neoadjuvant chemotherapy with S-1 and cisplatin followed by D2 gastrectomy with paraaortic lymph node dissection for gastric cancer with extensive lymph node metastasis","volume":"101","author":"Tsuburaya A","year":"2014","journal-title":"Br J Surg"},{"issue":"3","key":"ref21","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1002\/jso.22085","article-title":"Clinicopathologic variables predicting tumor response to neoadjuvant chemotherapy in patients with locally advanced gastric cancer","volume":"105","author":"Wang LB","year":"2012","journal-title":"J Surg Oncol"},{"issue":"3","key":"ref22","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1007\/s00280-019-03893-4","article-title":"Is pathologic tumor regression grade after neo-adjuvant chemotherapy a promising prognostic indicator for patients with locally advanced gastric cancer?","volume":"84","author":"Xu X","year":"2019","journal-title":"Cancer Chemother Pharmacol"},{"issue":"4","key":"ref23","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1007\/s10120-004-0294-3","article-title":"Retrospective analysis of clinical results and predictors of response in chemo-naive patients with advanced gastric cancer treated with S-1, an oral fluoropyrimidine derivative, as single-agent chemotherapy","volume":"7","author":"Yonemori K","year":"2004","journal-title":"Gastric Cancer"},{"issue":"1","key":"ref24","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/s12876-017-0598-5","article-title":"Comparison of five tumor regression grading systems for gastric adenocarcinoma after neoadjuvant chemotherapy: a retrospective study of 192 cases from National Cancer Center in China","volume":"17","author":"Zhu Y","year":"2017","journal-title":"BMC Gastroenterol"}],"container-title":["ABCD. Arquivos Brasileiros de Cirurgia Digestiva (S\u00e3o Paulo)"],"original-title":["Fatores preditivos de resposta histol\u00f3gica \u00e0 terapia neoadjuvante em adenocarcinomas g\u00e1stricos"],"link":[{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_pdf&pid=S0102-67202025000100336&tlng=en","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T15:05:18Z","timestamp":1766156718000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_arttext&pid=S0102-67202025000100336&tlng=en"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"references-count":24,"alternative-id":["S0102-67202025000100336"],"URL":"https:\/\/doi.org\/10.1590\/0102-67202025000043e1912","relation":{},"ISSN":["2317-6326","0102-6720"],"issn-type":[{"value":"2317-6326","type":"electronic"},{"value":"0102-6720","type":"print"}],"subject":[],"published":{"date-parts":[[2025]]},"article-number":"e1912"}}